BioSpace News Archive

Deals

AVITA Medical Added to S&P/ASX 200 Index

AVITA Medical announced that the company will be added to the S&P/ASX 200 index, effective upon market open on 14 November 2019, two months after being added to the S&P/ASX 300 index.

November 7, 2019
·
4 min read
Deals

CNS Pharmaceuticals Announces Pricing Of Initial Public Offering

CNS Pharmaceuticals, Inc., a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors, announced the pricing of its initial public offering of 2,125,000 shares of common stock at an offering price of $4.00 per share.

November 7, 2019
·
1 min read
Business

Aptevo Therapeutics Reports Third Quarter 2019 Financial Results

Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and reported its financial results for the third quarter ended September 30, 2019.

November 7, 2019
·
10 min read
Business

Zosano Pharma to Host Conference Call on Third Quarter 2019 Financial Results and Provide Operational Update

The Company will announce its financial results for this period in a press release to be issued prior to the call.

November 7, 2019
·
1 min read
Biotech Bay

Apixio Earns Coveted Spot on Deloitte’s 2019 Technology Fast 500 List of Fastest Growing Companies in North America

Apixio Inc., the AI healthcare analytics company, today announced it has ranked number 227 on the Deloitte Technology Fast 500™, a list of the fastest-growing companies in North America.

November 7, 2019
·
2 min read
BioMidwest

Lilly Announces the Early Tender Results and Upsizing of Its Pending Cash Tender Offer to Up to $2,000,006,000 Aggregate Principal Amount of Its Outstanding Debt Securities

Except as described in this press release, all other terms of the tender offer as described in the Offer to Purchase, dated October 24, 2019, and the related Letter of Transmittal remain unchanged.

November 7, 2019
·
7 min read
Business

INVO Bioscience Enters New Distribution Agreements in Africa to Commercialize the INVOcell In Vivo Fertilization System

Agreements with commercialization partners support INVO Bioscience’s planned worldwide rollout of INVOcell

November 7, 2019
·
5 min read
Drug Development

New analysis of patients with autoimmune-related ILDs in the INBUILD study shown as poster presentation at the 2019 ACR/ARP Annual Meeting

Boehringer Ingelheim presented results from a new subgroup analyses that support the primary endpoint results from the Phase III INBUILD® trial that showed Ofev® (nintedanib) reduced the rate of lung function decline in patients with autoimmune-related interstitial lung diseases (ILDs)

November 7, 2019
·
8 min read
Biotech Beach

CorTechs Labs Enters Phase 2 of $1.15 Million NIH Grant to Automate the Diagnosis and Prediction of Alzheimer’s Disease

Phase two of this grant proves CorTechs Labs’ PETQuant™ to be clinically and commercially viable

November 7, 2019
·
3 min read
Business

Vireo Health Names Bruce Linton as Executive Chairman

He will serve on the board of directors, work closely with Vireo CEO & Founder Kyle Kingsley, M.D., and spearhead the Company’s strategic decision-making, capital markets activity and future partnerships.

November 7, 2019
·
6 min read